Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Mast Therapeutics Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 300,000 488,959 0 0 0
Cost of Goods Sold (COGS) incl. D&A - 19,821 37,570 90,047 39,517
COGS excluding D&A - 0 0 0 0
Depreciation & Amortization Expense 79,728 19,821 37,570 90,047 39,517
Depreciation 79,728 19,821 37,570 90,047 39,517
Amortization of Intangibles - - - 0 0
Gross Income - 469,138 (37,570) (90,047) (39,517)
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 11.12M 9.01M 12.95M 15.61M 21.42M
Research & Development 6.28M 3.69M 5.76M 8.09M 12.9M
Other SG&A 4.84M 5.32M 7.19M 7.52M 8.52M
Other Operating Expense 0 0 0 0 0
Unusual Expense 383,000 0 410,885 (69,602) 79,640
EBIT after Unusual Expense (383,000) 0 (410,885) 69,602 (79,640)
Non Operating Income/Expense (46,535) (2,469) 60,367 (5,047) (1,352)
Non-Operating Interest Income 7,162 92,873 76,587 73,560 60,268
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 0 1,629 0 0 0
Gross Interest Expense 0 1,629 0 0 0
Interest Capitalized 0 0 0 0 0
Pretax Income (11.33M) (8.45M) (13.26M) (15.56M) (21.48M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (11.33M) (8.45M) (13.26M) (15.56M) (21.48M)
Minority Interest Expense 0 0 0 0 0
Net Income (11.33M) (8.45M) (13.26M) (15.56M) (21.48M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (11.33M) (8.45M) (13.26M) (15.56M) (21.48M)
Preferred Dividends 4.87M 5.64M 0 0 0
Net Income Available to Common (16.19M) (14.09M) (13.26M) (15.56M) (21.48M)
EPS (Basic) (3.50) (1.07) (0.47) (0.33) (0.28)
Basic Shares Outstanding 4.67M 13.18M 28.18M 47.64M 76.59M
EPS (Diluted) (3.50) (1.07) (0.47) (0.33) (0.28)
Diluted Shares Outstanding 4.67M 13.18M 28.18M 47.64M 76.59M
EBITDA (10.82M) (8.52M) (12.95M) (15.61M) (21.42M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.